1. Home
  2. RDY vs BG Comparison

RDY vs BG Comparison

Compare RDY & BG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • BG
  • Stock Information
  • Founded
  • RDY 1984
  • BG 1818
  • Country
  • RDY India
  • BG United States
  • Employees
  • RDY N/A
  • BG N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • BG Packaged Foods
  • Sector
  • RDY Health Care
  • BG Consumer Staples
  • Exchange
  • RDY Nasdaq
  • BG Nasdaq
  • Market Cap
  • RDY 13.1B
  • BG 13.5B
  • IPO Year
  • RDY N/A
  • BG N/A
  • Fundamental
  • Price
  • RDY $79.49
  • BG $89.39
  • Analyst Decision
  • RDY Buy
  • BG Buy
  • Analyst Count
  • RDY 1
  • BG 8
  • Target Price
  • RDY $87.00
  • BG $118.00
  • AVG Volume (30 Days)
  • RDY 156.2K
  • BG 1.5M
  • Earning Date
  • RDY 10-29-2024
  • BG 10-30-2024
  • Dividend Yield
  • RDY 1.20%
  • BG 3.04%
  • EPS Growth
  • RDY 17.48
  • BG N/A
  • EPS
  • RDY 4.00
  • BG 8.86
  • Revenue
  • RDY $3,460,984,788.00
  • BG $55,821,000,000.00
  • Revenue This Year
  • RDY $13.21
  • BG N/A
  • Revenue Next Year
  • RDY $8.56
  • BG $2.45
  • P/E Ratio
  • RDY $19.79
  • BG $10.09
  • Revenue Growth
  • RDY 10.49
  • BG N/A
  • 52 Week Low
  • RDY $63.72
  • BG $86.10
  • 52 Week High
  • RDY $84.46
  • BG $114.92
  • Technical
  • Relative Strength Index (RSI)
  • RDY 46.19
  • BG 29.40
  • Support Level
  • RDY $78.40
  • BG $88.26
  • Resistance Level
  • RDY $80.00
  • BG $97.27
  • Average True Range (ATR)
  • RDY 0.86
  • BG 1.61
  • MACD
  • RDY 0.11
  • BG -0.82
  • Stochastic Oscillator
  • RDY 58.28
  • BG 7.19

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About BG Bunge Limited

Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes, and corn-based products in North and South America.

Share on Social Networks: